Healthcare -
Biotechnology - NASDAQ - US
$ 26.125
-8.04 %
$ 499 M
Market Cap
-10.82
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Structure Therapeutics Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 158 M |
| Operating Income | -158 M |
| Other Expenses | -35.7 M |
| Net Income | -123 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 0.9 | 0.6 | 0.3 | 20 K |
| Gross Profit | 0 | (0.9) | (0.6) | (0.3) | 20 K |
| OPERATING INCOME | |||||
| Operating Expenses | 158.2 | 102.8 | 52.6 | 37.7 K | 15.9 K |
| Selling, General and Administrative Expenses | 49.4 | 32.7 | 16.4 | 8.58 K | 3.54 K |
| Research and Development Expenses | 108.8 | 70.1 | 36.2 | 29.1 K | 12.4 K |
| Operating Income | (158.2) | (102.8) | (52.6) | 37.7 K | 15.9 K |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 13.4 | 0 | 0.1 | 0 |
| Total Other Income | 36.0 | 13.4 | 1.3 | (0.1) | 0.2 |
| Pre-Tax Income | (122.2) | (89.4) | (51.3) | 37.8 K | 15.7 K |
| NET INCOME | |||||
| Tax Provision | 0.3 | 0.2 | 17 K | 231 | 138 |
| Net Income | (122.5) | (89.6) | (51.3) | 38 K | 15.9 K |
| EPS | 0.63 | 0.6 | 0.36 | 0.0003 | 0 |